UBS AM
NUVL

UBS AM’s Nuvalent NUVL Stock Holding History

UBS AM’s Portfolio NUVL Stock Details NUVL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.42M Sell
60,102
-62,085
-51% -$6.68M ﹤0.01% 1416
2026
Q1 		$12.5M Sell
122,187
-2,368
-2% -$241K ﹤0.01% 1085
2025
Q4 		$12.5M Buy
124,555
+59,138
+90% +$5.83M ﹤0.01% 1035
2025
Q3 		$5.66M Sell
65,417
-104,122
-61% -$8.23M ﹤0.01% 1313
2025
Q2 		$12.9M Buy
169,539
+19,598
+13% +$1.43M ﹤0.01% 1234
2025
Q1 		$10.6M Buy
149,941
+12,123
+9% +$948K ﹤0.01% 1195
2024
Q4 		$10.8M Sell
137,818
-3
-0% -$280 ﹤0.01% 1212
2024
Q3 		$14.1M Sell
137,821
-10,788
-7% -$895K ﹤0.01% 1086
2024
Q2 		$11.3M Buy
148,609
+50,486
+51% +$3.59M ﹤0.01% 1083
2024
Q1 		$7.37M Buy
98,123
+73,300
+295% +$5.83M ﹤0.01% 1109
2023
Q4 		$1.83M Buy
24,823
+8,123
+49% +$503K ﹤0.01% 1738
2023
Q3 		$768K Buy
16,700
+3,100
+23% +$138K ﹤0.01% 2101
2023
Q2 		$355K Hold
13,600
– – ﹤0.01% 2428
2023
Q1 		$355K Buy
13,600
+2,700
+25% +$79.9K ﹤0.01% 2428
2022
Q4 		$325K Buy
+10,900
New +$304K ﹤0.01% 2318

Other funds holding NUVL

DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $139B AUM 29.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.07B AUM 78.71% 1-Year Est. Return

UBS AM's NUVL Position: Q2 2026 in Review

UBS AM reduced its Nuvalent (NUVL) stake by 51% in Q2 2026, selling an estimated $6.68M and leaving 60,102 shares worth $7.42M. The position accounts for ﹤0.01% of the portfolio, ranked #1416.

UBS AM first reported a position in NUVL in Q4 2022 and has held it in 15 quarters since. The position peaked at $14.1M in Q3 2024. 293 funds tracked by Wall St. Rank hold NUVL as of Q2 2026.

  • UBS AM held 60,102 shares of Nuvalent worth $7.42M as of Q2 2026.
  • UBS AM sold 62,085 Nuvalent shares in Q2 2026, an estimated $6.68M.
  • Nuvalent made up ﹤0.01% of UBS AM's portfolio in Q2 2026, its #1416 holding.
  • UBS AM first reported a position in Nuvalent in Q4 2022 and has held it in 15 quarters since.
  • UBS AM's Nuvalent position peaked at $14.1M in Q3 2024.
  • 293 funds tracked by Wall St. Rank held Nuvalent as of Q2 2026.

Based on UBS AM's 13F filing for Q2 2026, filed 13 Aug 2026.